Lozen Pharma Profile
Key Indicators
- Authorised Capital ₹ 33.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 30.80 Cr
as on 17-06-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.45 Cr
as on 17-06-2024
- Revenue 69.08%
(FY 2022)
- Profit 660.67%
(FY 2022)
- Ebitda 1305.79%
(FY 2022)
- Net Worth 24.24%
(FY 2022)
- Total Assets 14.87%
(FY 2022)
About Lozen Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 33.00 Cr and a paid-up capital of Rs 30.80 Cr.
The company has closed loans amounting to ₹1.45 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Lozen Pharma Private Limited India is Renuka Gaggar as COMPANY SECRETARY. Gautam Ashra, Arjun Ashra, and Jugal Parekh serve as directors at the Company.
- CIN/LLPIN
U24239KA2009PTC068381
- Company No.
068381
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jan 2009
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Savanur, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Lozen Pharma Private Limited offer?
Lozen Pharma Private Limited offers a wide range of products and services, including Candy & Jelly, Flavoured Candies, Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Lozen Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Renuka Gaggar  | Company Secretary | 13-Jun-2019 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jugal Parekh | Director | 27-Nov-2020 | Current |
| Gautam Ashra | Director | 11-Aug-2023 | Current |
| Arjun Ashra | Director | 25-Oct-2016 | Current |
Financial Performance and Corporate Structure Insights of Lozen Pharma.
Lozen Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 69.08% increase. The company also saw a substantial improvement in profitability, with a 660.67% increase in profit. The company's net worth Soared by an impressive increase of 24.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lozen Pharma?
In 2022, Lozen Pharma had a promoter holding of 76.31% and a public holding of 23.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Aug 2016 | ₹1.00 Cr | Satisfied |
Karnataka State Financial Corporation Creation Date: 22 Dec 2011 | ₹4.50 M | Satisfied |
How Many Employees Work at Lozen Pharma?
Lozen Pharma has a workforce of 88 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lozen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lozen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
